Armata Pharmaceuticals Inc (ARMP)
2.59
-0.06
(-2.26%)
USD |
NYAM |
May 17, 16:00
2.64
+0.05
(+1.93%)
After-Hours: 20:00
Armata Pharmaceuticals Research and Development Expense (Annual): 33.77M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.77M |
| December 31, 2022 | 35.02M |
| December 31, 2021 | 20.02M |
| December 31, 2020 | 14.44M |
| December 31, 2019 | 9.824M |
| December 31, 2018 | 4.892M |
| December 31, 2017 | 2.881M |
| December 31, 2016 | 5.678M |
| December 31, 2015 | 3.992M |
| December 31, 2014 | 5.805M |
| December 31, 2013 | 6.469M |
| December 31, 2012 | 1.48M |
| December 31, 2008 | 15.18M |
| December 31, 2007 | 17.71M |
| Date | Value |
|---|---|
| December 31, 2006 | 14.48M |
| December 31, 2005 | 18.20M |
| December 31, 2004 | 17.29M |
| December 31, 2003 | 17.20M |
| December 31, 2002 | 29.39M |
| December 31, 2001 | 32.88M |
| December 31, 2000 | 47.99M |
| December 31, 1999 | 14.30M |
| December 31, 1998 | 13.30M |
| December 31, 1997 | 13.00M |
| December 31, 1996 | 11.50M |
| December 31, 1995 | 8.20M |
| December 31, 1994 | 6.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
9.824M
Minimum
2019
35.02M
Maximum
2022
22.61M
Average
20.02M
Median
2021
Research and Development Expense (Annual) Benchmarks
| AIM ImmunoTech Inc | 10.94M |
| Perspective Therapeutics Inc | 21.31M |
| Protalix BioTherapeutics Inc | 17.09M |
| Electromed Inc | 0.916M |
| Xtant Medical Holdings Inc | 1.336M |